Healthcare -
Biotechnology - NASDAQ - US
$ 2.55
-1.16 %
$ 97.7 M
Market Cap
-1.55
P/E
LPTX - COST OF REVENUE
Cost of Revenue LPTX - Leap Therapeutics, Inc.
427 K
LAST VALUE
0.00%
2 YEAR CAGR
54.19%
5 YEAR CAGR
0.00%
10 YEAR CAGR